Log in


+2.10 (+4.85 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: $45.36
50-Day Range
MA: $43.79
52-Week Range
Now: $45.36
Volume2.84 million shs
Average Volume1.61 million shs
Market Capitalization$9.94 billion
P/E RatioN/A
Dividend Yield0.92%
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.01 out of 5 stars

Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:XRAY



Sales & Book Value

Annual Sales$4.03 billion
Cash Flow$4.13 per share
Book Value$21.20 per share


Net Income$262.90 million


Market Cap$9.94 billion
Next Earnings Date11/5/2020 (Estimated)
+2.10 (+4.85 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

How has DENTSPLY SIRONA's stock been impacted by COVID-19 (Coronavirus)?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XRAY shares have increased by 6.6% and is now trading at $45.36.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of DENTSPLY SIRONA?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for DENTSPLY SIRONA

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for DENTSPLY SIRONA

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc (NASDAQ:XRAY) posted its quarterly earnings data on Thursday, August, 6th. The medical instruments supplier reported ($0.18) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.16. The medical instruments supplier had revenue of $490.60 million for the quarter, compared to analyst estimates of $492.55 million. DENTSPLY SIRONA had a negative net margin of 1.40% and a positive return on equity of 7.13%. The company's revenue was down 51.4% on a year-over-year basis. During the same period last year, the firm earned $0.66 earnings per share.
View DENTSPLY SIRONA's earnings history

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Wednesday, July 29th. Stockholders of record on Friday, September 25th will be given a dividend of $0.10 per share on Friday, October 9th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date of this dividend is Thursday, September 24th.
View DENTSPLY SIRONA's dividend history

What price target have analysts set for XRAY?

14 brokers have issued 1-year price targets for DENTSPLY SIRONA's shares. Their forecasts range from $38.00 to $66.00. On average, they anticipate DENTSPLY SIRONA's share price to reach $49.64 in the next twelve months. This suggests a possible upside of 9.4% from the stock's current price.
View analysts' price targets for DENTSPLY SIRONA

Has DENTSPLY SIRONA been receiving favorable news coverage?

News coverage about XRAY stock has trended negative recently, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. DENTSPLY SIRONA earned a daily sentiment score of -2.5 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about DENTSPLY SIRONA

Who are some of DENTSPLY SIRONA's key competitors?

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Gilead Sciences (GILD), IBM (IBM), Boeing (BA), General Electric (GE), Netflix (NFLX), Vertex Pharmaceuticals (VRTX) and Comcast (CMCSA).

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:
  • Mr. Nicholas William Alexos, Exec. VP & CFO (Age 55)
  • Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 50)
  • Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 58)
  • Mr. Donald M. Casey Jr., CEO & Director (Age 59)
  • Mr. Dominique P. Legros, Sr. VP of Equipment, Technologies & Healthcare Segment (Age 59)

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by a variety of institutional and retail investors. Top institutional investors include Nuance Investments LLC (3.06%), New York State Common Retirement Fund (0.88%), Sumitomo Mitsui Trust Holdings Inc. (0.70%), Swiss National Bank (0.42%), Victory Capital Management Inc. (0.40%) and Robeco Institutional Asset Management B.V. (0.38%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman and William E Newell.
View institutional ownership trends for DENTSPLY SIRONA

Which institutional investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Candriam Luxembourg S.C.A., Robeco Institutional Asset Management B.V., Mitsubishi UFJ Kokusai Asset Management Co. Ltd., Douglas Lane & Associates LLC, Mackay Shields LLC, Arizona State Retirement System, and First Trust Advisors LP. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Michael C Alfano, and William E Newell.
View insider buying and selling activity for DENTSPLY SIRONA

Which institutional investors are buying DENTSPLY SIRONA stock?

XRAY stock was purchased by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Victory Capital Management Inc., Sumitomo Mitsui Trust Holdings Inc., Reinhart Partners Inc., UBS Group AG, Boston Trust Walden Corp, Raymond James & Associates, and PGGM Investments. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, and Gregory T Lucier.
View insider buying and selling activity for DENTSPLY SIRONA

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $45.36.

How big of a company is DENTSPLY SIRONA?

DENTSPLY SIRONA has a market capitalization of $9.94 billion and generates $4.03 billion in revenue each year. The medical instruments supplier earns $262.90 million in net income (profit) each year or $2.45 on an earnings per share basis. DENTSPLY SIRONA employs 15,200 workers across the globe.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.